Advertisement
Screener

WILKINS INVESTMENT COUNSEL INC Historic Quarter Change: Foreign Stocks, Added

WILKINS INVESTMENT COUNSEL INC historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, WILKINS INVESTMENT COUNSEL INC opened 1 positions, added to 21, reduced 27 and sold out of 1.

  • Q3 2025: Stock BP; Country of operation —; Class ADR; Shares before 525,367.
  • Q3 2024: Stock BP; Country of operation —; Class ADR; Shares before 543,328.
  • Q2 2024: Stock NVS; Country of operation —; Class ADR; Shares before 187,737.
  • Q2 2024: Stock BP; Country of operation —; Class ADR; Shares before 533,190.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1276853), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-06); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-07); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-02); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-30); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-07); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-06); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-11); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-12); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-08); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-10); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-10); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-10); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-09); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-07); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-08); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-11); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-10); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-06); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-28); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-31); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-08). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2025BP
BP PLC
ADR525,367525,757+390$15,724,234$18,117,586+$2,393,3522025-10-30
Q3 2024BP
BP PLC
ADR543,328551,765+8,437$19,614,141$17,319,903-$2,294,2382024-11-12
Q2 2024NVS
NOVARTIS
ADR187,737188,969+1,232$18,159,800$20,117,640+$1,957,8402024-08-08
Q2 2024BP
BP PLC
ADR533,190543,328+10,138$20,090,599$19,614,141-$476,4582024-08-08
Q1 2024BP
BP PLC
ADR375,778533,190+157,412$13,302,541$20,090,599+$6,788,0582024-05-09
Q1 2024NVS
NOVARTIS
ADR130,110187,737+57,627$13,137,207$18,159,800+$5,022,5932024-05-09
Q3 2016NVS
Novartis AG (ADR)
COM94,15094,340+190$7,768,000$7,449,000-$319,0002016-11-10
Q3 2016BP
BP P.L.C.
COM229,642238,492+8,850$8,155,000$8,385,000+$230,0002016-11-10
Q2 2016BP
BP P.L.C.
COM202,560229,642+27,082$6,113,000$8,155,000+$2,042,0002016-08-10
Q2 2016NVS
Novartis AG (ADR)
COM90,40094,150+3,750$6,549,000$7,768,000+$1,219,0002016-08-10
Q1 2016BP
BP P.L.C.
COM181,839202,560+20,721$5,684,000$6,113,000+$429,0002016-05-10
Q1 2016NVS
Novartis AG (ADR)
COM75,18490,400+15,216$6,469,000$6,549,000+$80,0002016-05-10
Q3 2015BP
BP P.L.C.
COM173,867186,922+13,055$6,948,000$5,712,000-$1,236,0002015-11-09
Q2 2015BP
BP P.L.C.
COM171,316173,867+2,551$6,700,000$6,948,000+$248,0002015-08-07
Q4 2014BP
BP P.L.C.
COM169,794173,094+3,300$7,462,000$6,598,000-$864,0002015-02-11
Q2 2014BP
BP P.L.C.
COM164,494170,044+5,550$7,912,000$8,970,000+$1,058,0002014-08-06
Q2 2014NVS
Novartis AG (ADR)
COM78,35078,550+200$6,661,000$7,111,000+$450,0002014-08-06
Q1 2014BP
BP P.L.C.
COM152,591164,494+11,903$7,417,000$7,912,000+$495,0002014-04-28
Q4 2013BP
BP P.L.C.
COM148,136152,591+4,455$6,226,000$7,417,000+$1,191,0002014-01-31
Q4 2013NVS
Novartis AG (ADR)
COM78,67578,750+75$6,035,000$6,330,000+$295,0002014-01-31
Q3 2013BP
BP P.L.C.
COM146,836148,136+1,300$6,129,000$6,226,000+$97,0002013-11-08

Similar Firms

Firm NameCountry13F ValueHoldings
Tensile Capital Management LPUnited States$0.698B25
Kelman-Lazarov, Inc.United States$0.698B140
SILVERBACK ASSET MANAGEMENT LLCUnited States$0.699B63
IFC Advisors LLCUnited States$0.699B158
Allied Investment Advisors, LLCUnited States$0.697B100
Sio Capital Management, LLCUnited States$0.697B76
Abundance Wealth CounselorsUnited States$0.697B246
Golden Unicorn (BVI) LtdBritish Virgin Islands$0.697B4
FOURPATH CAPITAL MANAGEMENT, LLCUnited States$0.697B218
ACADEMY CAPITAL MANAGEMENTUnited States$0.699B38